It was initially reported by compassion 3 clinical trial, the patient had a 29mm sapien 3 valve implanted in an existing edwards surgical valve in the pulmonic position.The pacemaker atrial lead wire was displaced during delivery system removal.An electorphysiology physician (ep) was was consulted, and patient went to implantable cardioverter defibrillator (icd) extraction with replacement.The event was discovered by during a monitoring visit.
|
Update to h6, device code, type of investigation, investigation findings and investigation conclusion.Update to trial name: compassion s3 pas trial.The commander delivery system was not returned to edwards lifesciences for evaluation; therefore, no visual inspection, functional testing and dimensional testing is applicable.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure mode is not required at this time.The following instructions for use (ifu) were reviewed: commander delivery system with s3/s3u.Based on this review, no ifu training deficiencies were identified.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure mode is not required at this time.The complaint for interventional device interacts with permanent pacemaker lead was unable to be confirmed due to lack of the returned device or applicable imagery.Due to the unavailability of the device, engineering was unable to perform any visual, functional, or dimensional analysis.Therefore, a manufacturing non-conformance was unable to be determined.A review of the dhr and lot history did not provide any indication that a manufacturing non-conformance would have contributed to the complaint event.A review of the ifu and training manuals revealed no deficiencies.As reported, "a 29mm sapien 3 valve implanted in an existing edwards surgical valve in the pulmonic position.The pacemaker atrial lead wire was displaced during delivery system removal." guidance in pulmonic procedural training manuals instruct the operator on patient screening, size verification, and landing zone site preparation, in addition to proper withdrawal technique of the delivery system.If the operator did not properly follow withdrawal techniques this may have resulted in the delivery system getting caught on the permanent pacemaker lead during withdrawal, resulting in the reported interaction with permanent pacemaker lead.In this case, available information suggests procedural factors (improper withdrawal technique) may have contributed to the reported event.Without the return of applicable imagery, a conclusive root cause is unable to be determined.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.No ifu training deficiencies were identified for these reported.Therefore, no product risk assessment (pra) nor corrective or preventive actions are required for these events.
|
The complaint for interventional device interacting with permanent pacemaker lead was confirmed empirically from medical records.Due to the unavailability of the device, engineering was unable to perform any visual, functional, or dimensional analysis.Therefore, a manufacturing non-conformance was unable to be determined.A review of the ifu and training manuals revealed no deficiencies.
|